Enacted stigma involves experiences of negative treatment, including discrimination, 9 stereotyping, and prejudice, at the hands of others in the past or the present (Earnshaw et  10 al., 2013; Scambler & Hopkins, 1986 ). In addition to experiencing enactments of stigma, 11 PLHIV may also expect negative treatment from others in the future, a phenomenon known 12 as anticipated stigma (Link, Cullen, Frank, & Wozniak, 1987) . 13 
14
Among PLHIV, internalized stigma has been associated with worse mental health 15 (Simbayi et would provide an impetus for investment in anti-stigma interventions. To help answer this 6 question, we used longitudinal data from a sample of PLHIV in South Africa, where a recent 7 nationwide study revealed high levels of internalized, anticipated, and enacted stigma 8 among PLHIV (Simbayi et al., 2016 ). We assessed changes over time in multiple dimensions 9 of HIV-related stigma among a sample of predominantly Black, newly diagnosed, and ART-10 eligible South Africans. We also sought to understand the extent to which ART initiation is 11 associated with changes in these dimensions of stigma and whether the association 12 between ART initiation and change in stigma differs by sex. 13 

Methods
15
Study design 16
Data for this analysis were drawn from a study that was conducted at three sites in 17 unequivocally to internalized stigma, including items on feelings of shame and/or self-2 hatred, whereas two items relate more closely to disclosure concerns ( Figure 1 ). We 3 regarded disclosure concerns as a correlate of anticipated stigma. There is recent evidence 4 for a two-factor structure for the IARSS items, including a four-item internalized stigma 5 factor and a two-item disclosure concerns factor, among PLHIV in India (Chan et al., 2018). 6
Therefore, we conducted a confirmatory factor analysis on the IARSS items using a two-7 factor structure. The Chi-sq statistic had a p-value of <0.01 with a root mean square error 
Statistical analysis 4
We used descriptive statistics to characterize the sample and levels of stigma at 5 baseline, three months, and six months, including McNemar's tests for the binary stigma 6 outcomes and paired t-tests for the stigma scales. To help understand to what extent 7 changes over time in stigma were related to non-random attrition of study participants, we 8 fitted a logistic regression model with attrition by six months as the outcome variable and 9 baseline disclosure concerns score or internalized stigma score as the primary exposure of 10 interest, adjusted for sociodemographic characteristics, CD4+ count, and study site (Soweto 11 vs. Gugulethu). We then fitted logistic regression models to the data with ART initiation as 12 the primary exposure of interest and disclosure concerns / internalized stigma (=1 if study 13 participant endorsed either disclosure concerns item or any of the four internalized stigma 14 items) at six months as the outcome variable, adjusted for sociodemographic 15 characteristics, CD4+ count, study site, and disclosure concerns / internalized stigma at 16 baseline. A statistically significant regression coefficient was considered evidence that an 17 association existed between ART initiation and disclosure concerns/internalized stigma at 18 six-month follow-up. As a sensitivity analysis, we fitted binomial regression models using 19 the disclosure concerns score (0-2) or internalized stigma score (0-4) (expressed as R of N, 20 where R is the participant's score and N is the maximum possible score) as the outcome 21 variable (adjusted for sociodemographic characteristics, CD4+ count, study site and 22 disclosure concerns / internalized stigma score at baseline). Finally, we fitted all models 1 with a product term to test for an interaction between sex and ART initiation. All analyses 2 were performed using Stata software (Version 15.0, StataCorp, College Station, TX, USA). 3 4
Results
5
We enrolled 500 participants (200 in Soweto and 300 in Gugulethu) into the study 6 (Table) . A total of 308 (62%) participants initiated ART within six months; nine (2%) 7 participants died before accessing treatment. We located and verified clinical data for 473 8 (95%) of the participants in this cohort through NHLS. Three hundred and eighty-three 9 (81%) participants had complete follow-up survey data through six months. At baseline 10 (i.e., one week after testing, at the determination of ART eligibility), disclosure concerns 11 were particularly high, with 78% endorsing at least one disclosure concern item (Figure 1) . 12
Internalized stigma at baseline was also common, with 46% endorsing at least one 13 internalized stigma item, including 35% who agreed with the statement "I feel guilty that I 14 am HIV positive." 15
16
Internalized stigma declined over six months among participants (mean score, 1.0 17 to 0.7, p<0.01), including ART non-initiators (1.1 to 0.8, p<0.01) and ART initiators (1.0 to 18 0.7, p<0.01). There were declines in the percentages agreeing with each of the four 19 internalized stigma items. Nevertheless, 39% of participants, including 40% of ART non-20 initiators and 38% of ART initiators, continued to endorse at least one internalized stigma 21 item after six months (Figures 2 and 3 Using logistic regression models adjusted for sociodemographic variables, baseline 11 CD4+ count, study site, and baseline disclosure concerns / internalized stigma, we 12 estimated a statistically significant positive association between ART initiation and 13 disclosure concerns at six months (OR=1.88; 95% CI, 1.20-2.94) but not between ART 14 initiation and internalized stigma at six months (OR=1.15; 95% CI, 0.75-1.78). In the 15 models including a product term testing for an interaction between sex and ART initiation, 16 the estimated regression coefficient for the product term was not statistically significant 17 for either the association between ART initiation and disclosure concerns (p=0.40) or the 18 association between ART initiation and internalized stigma (p=0.90). 19
20
The sensitivity analysis using binomial regression models for the disclosure 21 concerns score (0-2) / internalized stigma score (0-4) as the outcome variable yielded 22 similar results. We estimated a statistically significant positive association between ART 1 initiation and disclosure concerns score at six months (adjusted b=0.44; 95% CI, 0.11-0.76) 2 but not between ART initiation and internalized stigma score at six months (adjusted b= -3 0.05; 95% CI, -0.34 to 0.24). In the models including a product term testing for an 4 interaction between gender and ART initiation, the estimated regression coefficient for the 5 product term was again not statistically significant for either the association between ART 6 initiation and disclosure concerns (p=0.50) or the association between ART initiation and 7 internalized stigma (p=0.15). The regression estimates for all models used in this analysis 8 are available in Supplementary Digital Content 2. Although women appear to be more likely than men in the general population of sub-21
Saharan Africa to hold stigmatizing attitudes (Chan et al., 2015), our findings indicate that 22 this may not necessarily translate into women being more likely than men to internalize 1 stigma after HIV diagnosis. Moreover, we did not find that the association between ART 2 initiation and change in stigma differs significantly by sex. Our results suggest that 3 interventions to counter stigma and to promote serostatus disclosure among PLHIV should 4 target both women and men. 5
6
Our study has several limitations. First, our results may have been biased by the 7 substantial rate of loss to follow-up, which affected about one-quarter of the enrolled 8 participants. However, concern for non-random attrition of participants is mitigated by the 9 lack of a statistically significant association between disclosure concerns or internalized 10 stigma at baseline and attrition by six months. Moreover, any differential loss to follow-up 11 would have likely biased our estimates of persisting stigma toward the null (because 12 persistent stigma may have caused study participants to select out of the study, further 13 enriching the sample for participants with lower levels of stigma)-buttressing our 14 conclusion that stigma remains persistently high among PLHIV who access HIV care. understandably decided against public disclosure, while garnering social support from 1 select family and friends to whom they have disclosed. However, we feel that the use of the 2 terms "hide" and "difficult" grants these items a negative connotation that likely reflects 3 fears of rejection and exclusion that go beyond "normal" privacy concerns. 
